Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
EK ›
EKSTERMED
Trademark search for:
EKSTERMED
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-09-03 — Application filed
2020-09-07 — Application filed
2020-10-08 — Application filed
2020-10-09 — Notice of design search code e-mailed
2021-01-08 — Assigned to examiner
2021-01-13 — Examiners amendment -written
2021-01-13 — Examiners amendment e-mailed
2021-01-13 — Notification of examiners amendment e-mailed
2021-01-14 — Examiner's amendment entered
2021-01-14 — Assigned to lie
2021-01-15 — Approved for pub - principal register
2021-02-03 — Notification of notice of publication e-mailed
2021-02-23 — Published for opposition
2021-02-23 — Official gazette publication confirmation e-mailed
2021-04-20 — Noa e-mailed - sou required from applicant
2021-10-18 — Sou teas extension received
2021-10-18 — Sou extension 1 filed
2021-10-25 — Case assigned to intent to use paralegal
2021-10-26 — Sou extension 1 granted
2021-10-27 — Notice of approval of extension request e-mailed
2022-04-15 — Sou teas extension received
2022-04-15 — Sou extension 2 filed
2022-04-15 — Sou extension 2 granted
2022-04-19 — Notice of approval of extension request e-mailed
2022-10-17 — Sou teas extension received
2022-10-17 — Sou extension 3 filed
2022-10-17 — Sou extension 3 granted
2022-10-19 — Notice of approval of extension request e-mailed
2023-04-17 — Sou teas extension received
2023-04-17 — Sou extension 4 granted
2023-04-17 — Sou extension 4 filed
2023-04-19 — Notice of approval of extension request e-mailed
2023-10-16 — Sou teas extension received
2023-10-16 — Sou extension 5 filed
2023-10-18 — Sou extension 5 granted
2023-10-19 — Notice of approval of extension request e-mailed
2024-05-27 — Application abandoned
2024-05-27 — Final status recorded
2024-07-12 — Application abandoned
Owner Information
Teikoku Pharma USA, Inc.
Teikoku Pharma USA, Inc.
Correspondent
Bret E. Field BOZICEVIC, FIELD & FRANCIS LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
